Malaria Treatment Market Size & Share | Statistics Report 2028

Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)

Publication Month : Nov 2022

  • Report Code : TIPRE00018229
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 291
Inquire Before Buy



The malaria treatment market is expected to reach US$ 2,291.49 million by 2028; it is expected to grow at a compound annual growth rate of 4.9% from 2022 to 2028.

Malaria is a life-threatening infectious disease caused by the Plasmodium parasite. The malaria treatment market is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing launch of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the malaria treatment market.


Market Insights

Government and Private Sector Initiatives to Raise Awareness About Malaria Drive Market Growth

Malaria awareness campaigns help enhance knowledge regarding the disease , improve behaviors promoting health, and promote intersectoral collaboration and social support. The WHO is responsible for coordinating the Global Malaria Programme (GMP) as part of its global efforts to control and eradicate malaria. The program is led by the "Global Technical Strategy for Malaria 2016–2030," which was adopted by the World Health Assembly in May 2015 and was further restructured in 2021. The WHO observes 25 April as World Malaria Day every year to highlight the collective energy and commitment of the malaria communities across the world in uniting for the common objective of freeing the world from malaria.

In 2016, India introduced its first National Framework for Malaria Elimination, which will be valid from 2016 through 2030. In 2019, the Indian government raised funding by more than 25% for the National Vector Borne Disease Control Programme, launched in 2003. The country has also increased its contribution as a donor to the Global Fund to Fight Malaria. Further, in the US, efforts for controlling malaria are made primarily through the President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to the Global Health Policy, the US planned the funding of ~US$ 1 billion in FY 2022 for malaria control and research activities. The goal of the US government under the PMI Strategy 2021–2026 is to manage malaria and reduce deaths caused by it, along with a long-term aim of eradicating the disease.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Malaria Treatment Market: Strategic Insights

Market Size Value inUS$ 1,638.27 Million in 2021
Market Size Value byUS$ 2,291.49 Million by 2028
Growth rateCAGR of 4.9% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst


Several governments of various countries across the globe are taking initiatives to create awareness and conduct research for the development of new antimalarial drugs and vaccines. As per the WHO data, total funding for the control and elimination of malaria reached ~US$ 3 billion in 2019; governments of endemic countries, collectively, contributed 31% (~US$ 900 million) of the total fund to create awareness and development of new vaccines. Private companies are also engaging in the fight against malaria and investing heavily in R&D activities. For instance, in 2018, Novartis invested more than US$ 100 million to enhance its research and development activities for next-generation treatments by 2023.

Governments in countries with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to treatment and helping communities in malaria-endemic countries in delivering better healthcare. A few of these initiatives are mentioned below.

  • Myanmar has a national malaria control plan that is approved by the Global Fund, and it expects to eliminate the disease caused by P. falciparum by 2030. The universal healthcare coverage in the country includes access to malaria diagnosis by microscopy or rapid diagnostic tests (RDTs) and the availability of artemisinin-based combination therapies (ACTs).
  • Thailand has implemented the National Strategic Plan for Malaria Elimination that applies an integrated elimination strategy for the elimination of the disease by 2024.
  • In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021–2023. This plan aims to reach millions of people with malaria control interventions and scale up prevention activities in the region.
  • Abbott collaborated with “Malaria No More” (a nonprofit organization to eradicate malaria) and the Government of Odisha, India, to provide technology, expertise, and funding to facilitate advanced efforts to end malaria in the state. In January 2019, Abbott announced its plans to supply one million RDTs to strengthen Odisha's malaria diagnosis and surveillance system. The company also announced its plans to support “Malaria No More” with the financial aid of US$ 750,000 to support the malaria elimination strategy in the state.

Such initiatives by government and private companies to spread awareness about malaria and reinforce malaria eradication efforts are bolstering the malaria treatment market growth.

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into prescription medications, vaccines, diagnostic tests, and others. The prescription medications are further segmented into chloroquine phosphate, artemisinin-based combination therapies (acts), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others. The diagnostic tests segment held the largest market share of US$ 685.69 million in 2021.

Malaria Treatment Market, by Type – 2021 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Drug Type-Based Insights

The malaria treatment market is bifurcated based on drug type into branded and generic. The generic segment accounted for a larger share of the malaria treatment market in 2021; however, the branded segment is expected to register a higher CAGR of 5.5% during the forecast period.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2021; however, the parenteral & intravenous segment is expected to register the highest CAGR of 5.4% during the forecast period.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the malaria treatment market in 2021; however, the online pharmacies segment is expected to register the highest CAGR of 6.9% during the forecast period.

End User-Based Insights

Based on drug type, the malaria treatment market is categorized into hospitals, specialty clinics, home care, and others. The hospital’s segment accounted for the largest share of the market in 2021; however, the specialty clinics segment is expected to register the highest CAGR of 5.5% during the forecast period.


Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the DVT preventive pump market. The recent key market developments are listed below:

  • In January 2022, with the power of partnerships and regular collaborations with The Bill & Melinda Gates Foundation, World Vision, and the President’s Malaria Initiative. Malaria Partners International (MPI) was a key partner in the launch of Rotary’s first Programs of Scale grant, Partners for a Malaria-Free Zambia. With other partners, especially Rotary Clubs in Africa, MPI has supported various projects ranging from small community-based projects to larger global grants. MPI’s Small Grants Program empowers Rotary Clubs in malaria-endemic regions to take direct action to control malaria in their communities. Each project addresses needs carefully defined by community leaders, uses current best practices, and provides measurable goals.
  • In December 2021, Cadila Healthcare (Zydus Cadila), a drug-making company, announced its plan for the ongoing development of antimalarial drug ZY19489 (MMV253), with Medicines for Malaria Venture (MMV), which received orphan drug designation from the USFDA. 

Company Profiles

  • Zydus Healthcare Ltd         
  • Sun Pharmaceutical Industries Ltd           
  • Sanofi SA     
  • GSK Plc       
  • Novartis AG            
  • Cipla Ltd      
  • Viatris Inc    
  • Lupin Ltd     
  • AdvaCare Pharma USA LLC           
  • VLP Therapeutics LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Treatment, Drug Type, Route of Administration, Distribution Channel, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Burkina Faso, Canada, China, Congo, Democratic Republic of, France, Germany, Ghana, India, Italy, Japan, Kenya, Mexico, Mozambique, Nigeria, Saudi Arabia, South Africa, South Korea, Spain, Tanzania, Uganda, United Arab Emirates, United Kingdom, United States, Zambia

Frequently Asked Questions

What is the regional market scenario of the malaria treatment market?

Malaria treatment market is segmented by countries comprising of North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

Who are the key players in the malaria treatment market?

Zydus Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc, Lupin Ltd, AdvaCare Pharma USA LLC, and VLP Therapeutics LLC among others are among the leading companies operating in the malaria treatment market.

Which end user segment held the largest market share in the malaria treatment market?

Based on the end user, hospital segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which treatment segment held the largest market share in the malaria treatment market?

The diagnostics segment dominated the malaria treatment market and accounted for the largest market share in 2021.

What is meant by the malaria treatment market?

Malaria is a serious infection spread by an infected mosquito. The infection is very common in certain parts of the world, such as large areas of Africa and Asia, Central and South America, and the Dominican Republic and Haiti. However, malaria is an entirely preventable and treatable disease if tackled at an early stage. For example, malaria is treated with a prescription drug to kill the parasite. The types of drugs and the length of treatment vary depending on the type of malarial parasite infection, the severity of symptoms, and age.

What are the driving factors for the malaria treatment market across the globe?

Increasing prevalence of malaria and government and private sector's initiative to raise awareness about malaria are the most significant factors responsible for the overall market growth.

Which route of administration segment led the malaria treatment market?

Based on route of administration, the oral segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

The List of Companies - Malaria Treatment Market

  1. Zydus Healthcare Ltd         
  2. Sun Pharmaceutical Industries Ltd           
  3. Sanofi SA     
  4. GSK Plc       
  5. Novartis AG            
  6. Cipla Ltd      
  7. Viatris Inc    
  8. Lupin Ltd     
  9. AdvaCare Pharma USA LLC           
  10. VLP Therapeutics LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports